###begin article-title 0
GSK-3beta Is Required for Memory Reconsolidation in Adult Brain
###end article-title 0
###begin p 1
Conceived and designed the experiments: TK AT. Performed the experiments: TK SY SN JMP MM. Analyzed the data: TK YY NS. Contributed reagents/materials/analysis tools: TM. Wrote the paper: AT.
###end p 1
###begin p 2
###xml 354 358 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
###xml 501 505 <span type="species:ncbi:10090">mice</span>
###xml 634 638 <span type="species:ncbi:10090">mice</span>
###xml 663 667 <span type="species:ncbi:10090">mice</span>
###xml 821 825 <span type="species:ncbi:10090">mice</span>
###xml 926 930 <span type="species:ncbi:10090">mice</span>
###xml 1057 1061 <span type="species:ncbi:10090">mice</span>
###xml 1175 1179 <span type="species:ncbi:10090">mice</span>
Activation of GSK-3beta is presumed to be involved in various neurodegenerative diseases, including Alzheimer's disease (AD), which is characterized by memory disturbances during early stages of the disease. The normal function of GSK-3beta in adult brain is not well understood. Here, we analyzed the ability of heterozygote GSK-3beta knockout (GSK+/-) mice to form memories. In the Morris water maze (MWM), learning and memory performance of GSK+/- mice was no different from that of wild-type (WT) mice for the first 3 days of training. With continued learning on subsequent days, however, retrograde amnesia was induced in GSK+/- mice, suggesting that GSK+/- mice might be impaired in their ability to form long-term memories. In contextual fear conditioning (CFC), context memory was normally consolidated in GSK+/- mice, but once the original memory was reactivated, they showed reduced freezing, suggesting that GSK+/- mice had impaired memory reconsolidation. Biochemical analysis showed that GSK-3beta was activated after memory reactivation in WT mice. Intraperitoneal injection of a GSK-3 inhibitor before memory reactivation impaired memory reconsolidation in WT mice. These results suggest that memory reconsolidation requires activation of GSK-3beta in the adult brain.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 88 91 81 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Woodgett1">[1]</xref>
###xml 243 246 233 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Grimes1">[2]</xref>
###xml 247 250 237 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Takashima1">[4]</xref>
###xml 444 447 428 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Jope1">[3]</xref>
###xml 597 600 581 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Takashima1">[4]</xref>
###xml 601 604 585 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-OBrien1">[7]</xref>
Two GSK-3 isoforms (alpha and beta) are encoded by different genes in mammalian tissues [1]. GSK-3beta is highly enriched in the brain, where it phosphorylates metabolic enzymes, signal proteins, structural proteins, and transcription factors [2]-[4]. GSK-3beta is a constitutively active kinase. Most GSK-3beta substrates are under negative regulation, which is relieved by Ser9 phosphorylation through other kinases such as PKC, PKA, and Akt [3]. GSK-3 inhibitor experiments suggest that GSK-3 may be involved in mood disorders, schizophrenia, and pathogenesis of neurofibrillary tangles (NFTs) [4]-[7].
###end p 4
###begin p 5
###xml 108 111 108 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Goedert1">[8]</xref>
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Lee1">[10]</xref>
###xml 207 211 204 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Engel1">[11]</xref>
###xml 212 216 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Takashima2">[14]</xref>
###xml 331 334 328 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Takashima1">[4]</xref>
###xml 336 340 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Noble1">[15]</xref>
###xml 438 442 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Takashima2">[14]</xref>
###xml 444 448 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Takashima3">[16]</xref>
###xml 450 454 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Takashima4">[17]</xref>
###xml 571 575 559 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Engel2">[18]</xref>
###xml 577 581 565 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Hernandez1">[19]</xref>
###xml 559 564 <span type="species:ncbi:10090">mouse</span>
NFTs, neuropathological hallmarks of neurodegenerative disorders, are composed of highly phosphorylated tau [8]-[10]. GSK-3beta is an enzyme potentially involved in forming highly phosphorylated tau in NFTs [11]-[14]. This hypothesis is supported by the observation that a GSK-3 inhibitor prevents NFT formation in an animal model [4], [15]. Aggregated Abeta activates GSK-3beta and induces hyperphosphorylation of tau and neuronal death [14], [16], [17]. Furthermore, the overexpression of GSK-3beta affects spatial memory and accelerates NFT formation in a mouse model [18], [19]. This accumulating evidence suggests that activation of GSK-3beta may be involved in NFT formation and neuronal loss in neurodegenerative diseases, including Alzheimer's disease (AD).
###end p 5
###begin p 6
One hypothesis explaining the role of GSK-3beta in the adult brain posits that under normal conditions, GSK-3beta is inhibited and does not affect brain function. However, in disease states, GSK-3beta becomes activated through the elimination of inactivation signals, leading to neurodegeneration. This hypothesis provides the basis for the development of GSK-3beta inhibitors as potential therapeutic drugs for treating AD and other neurodegenerative diseases. However, it is inconceivable that a constitutively active kinase such as GSK-3beta exists for the purpose of neurodegeneration.
###end p 6
###begin p 7
###xml 25 29 25 29 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Peineau1">[20]</xref>
###xml 650 653 629 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 781 784 760 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
###xml 785 789 <span type="species:ncbi:10090">mice</span>
Recently, Peineau et al. [20] reported the importance of GSK-3beta activity during the induction of long term depression (LTD), suggesting that GSK-3beta activity may contribute to the control of synaptic plasticity and memory function. If GSK-3beta is involved only in neurodegeneration, then a genetic reduction of GSK-3beta would not be expected to affect cognitive function. On the other hand, if GSK-3beta is involved in normal brain function, a genetic reduction of GSK-3beta would be expected to affect cognitive function. To test this hypothesis, we compared memory formation and maintenance of heterozygous GSK-3beta gene-deficient mice (GSK+/-) and their wild-type (WT) littermates using the Morris water maze (MWM) test and a contextual fear-conditioning (CFC) test. GSK+/- mice lacked the ability to maintain memory after recall, suggesting GSK-3beta importantly contributes to memory maintenance after recall in normal brains.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
###xml 38 41 38 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
Generation and characterization of GSK+/-
###end title 9
###begin p 10
###xml 137 141 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Hoeflich1">[21]</xref>
###xml 197 200 188 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 244 247 232 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 355 358 340 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 432 439 417 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003540.s001">Fig. S1</xref>
###xml 465 469 450 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Hoeflich1">[21]</xref>
###xml 474 477 459 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 659 666 644 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003540.s002">Fig. S2</xref>
###xml 798 805 776 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003540.s001">Fig. S1</xref>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
To understand the normal role of GSK-3beta in the adult brain, we generated GSK-3beta gene-deficient mice according to published methods [21] and analyzed heterozygous GSK-3beta gene-deficient (GSK+/-) mice. The total amount of GSK-3beta in GSK+/- mice was approximately 50% of that in WT littermate mice, whereas the relative activity of GSK-3beta in GSK+/- mice was about 70% of that in WT littermates (see Supporting information Fig. S1). As previously reported [21], GSK+/- mice were healthy, fertile, had normal circadian rhythms and life span, but had unimpaired motor and locomotor activity compared to their WT littermates (see Supporting information Fig. S2). This was the case even though they had reduced GSK-3beta activity and lacked GSK-3alpha compensation (see Supporting information Fig. S1).
###end p 10
###begin title 11
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
GSK+/- mice exhibited retrograde amnesia with repeated training in MWM
###end title 11
###begin p 12
###xml 474 481 474 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003540.s003">Fig. S3</xref>
###xml 484 494 484 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g001">Fig. 1A, B</xref>
###xml 598 601 598 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 718 725 718 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g001">Fig. 1A</xref>
###xml 807 810 807 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 891 898 891 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g001">Fig. 1D</xref>
###xml 980 983 980 983 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1247 1254 1247 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g001">Fig. 1B</xref>
###xml 1294 1297 1294 1297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1407 1410 1407 1410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1473 1480 1473 1480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g001">Fig. 1E</xref>
###xml 1495 1498 1495 1498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1538 1545 1538 1545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g001">Fig. 1E</xref>
###xml 1593 1600 1593 1600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g001">Fig. 1F</xref>
###xml 1650 1653 1650 1653 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1832 1835 1832 1835 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1850 1857 1850 1857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g001">Fig. 1E</xref>
###xml 6 10 <span type="species:ncbi:10090">mice</span>
###xml 260 265 <span type="species:ncbi:10090">mouse</span>
###xml 392 397 <span type="species:ncbi:10090">mouse</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 602 606 <span type="species:ncbi:10090">mice</span>
###xml 712 716 <span type="species:ncbi:10090">mice</span>
###xml 811 815 <span type="species:ncbi:10090">mice</span>
###xml 885 889 <span type="species:ncbi:10090">mice</span>
###xml 984 988 <span type="species:ncbi:10090">mice</span>
###xml 1009 1013 <span type="species:ncbi:10090">mice</span>
###xml 1104 1108 <span type="species:ncbi:10090">mice</span>
###xml 1152 1156 <span type="species:ncbi:10090">mice</span>
###xml 1298 1302 <span type="species:ncbi:10090">mice</span>
###xml 1411 1415 <span type="species:ncbi:10090">mice</span>
###xml 1499 1503 <span type="species:ncbi:10090">mice</span>
###xml 1554 1558 <span type="species:ncbi:10090">mice</span>
###xml 1654 1658 <span type="species:ncbi:10090">mice</span>
###xml 1731 1735 <span type="species:ncbi:10090">mice</span>
###xml 1784 1788 <span type="species:ncbi:10090">mice</span>
###xml 1836 1840 <span type="species:ncbi:10090">mice</span>
Adult mice (7-14 months old) were trained 3 times a day to find a fixed but hidden platform submerged in a circular pool; training occurred for 3 or 9 days. Memory performance was measured in terms of an error score, which represents the cumulative distance a mouse traveled in each trial as it searched to find the hidden platform. The error score more accurately and sensitively reflects a mouse's place preference in a trial than other parameters (Supporting information Fig. S3). Fig. 1A, B show the average error scores of the mice during the training. During the first 3 days of training, GSK+/- mice learned to navigate to the hidden platform and had low error scores comparable to those of WT littermate mice (Fig. 1A). In the probe test, which was conducted after 3 days of continuous training, GSK+/- mice recognized the place where the platform used to be as well as the WT mice (Fig. 1D). However, with more than 3 days of continuous training (9 days of training), GSK+/- mice took longer than WT mice to locate the hidden platform. Their error scores increased, while the error scores of WT mice decreased steadily, indicating that the WT mice had effectively learned the location of the platform during the additional training days (Fig. 1B). To evaluate the spatial memory of GSK+/- mice, we conducted a probe test 24 h after the last session on the ninth training day. In the probe test, GSK+/- mice did not show statistically significant place preference (Fig. 1E). However, GSK+/- mice that received 3 days of training (Fig. 1E) and WT mice that received 9 days of training (Fig. 1F) did show significant place preference. Thus, GSK+/- mice failed to locate the previous location of the hidden platform, while WT mice located the platform easily, indicating that WT mice had retained place recognition, whereas GSK+/- mice did not (Fig. 1E).
###end p 12
###begin title 13
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Analysis of place learning and memory in GSK-3beta heterozygous mice.
###end title 13
###begin p 14
###xml 103 106 103 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 240 247 240 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003540.s005">Fig. S5</xref>
###xml 820 823 820 823 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 842 846 <span type="species:ncbi:10090">mice</span>
The Morris water maze (MWM) was used to assess place learning and memory of adult WT littermate and GSK+/- mice (7-14 months old). The cognitive function of 7- to 14-month-old mice did not show age-dependent decline (Supporting information Fig. S5). Memory was assessed after 3 days of continuous training (A, D); 9 days of continuous training (B, E); and 3 days of reversal testing following the 9-day continuous training session (C, F). Learning is expressed as error scores (A, B, C), and memory performance is expressed as a percentage of total time spent in the target quadrant during the probe test (D, E, F). The probe test was given on the fourth day (D, F) or tenth day (E) of the experiment (see Methods). Differences between genotypes were statistically analyzed with a two-way ANOVA (A-C). Dwell times of GSK+/- and WT littermate mice spent in the target (T), adjacent (A), and opposite (O) quadrants were statistically analyzed by one-way ANOVA (d-f). Results are expressed as means+/-SEM.
###end p 14
###begin p 15
###xml 178 185 178 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g001">Fig. 1A</xref>
###xml 191 194 191 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 281 288 281 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g001">Fig. 1C</xref>
###xml 358 365 358 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g001">Fig. 1F</xref>
###xml 470 473 470 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 583 590 583 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003540.s004">Fig. S4</xref>
###xml 825 828 825 828 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 858 865 858 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003540.s005">Fig. S5</xref>
###xml 1009 1012 1009 1012 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 492 496 <span type="species:ncbi:10090">mice</span>
###xml 738 742 <span type="species:ncbi:10090">mice</span>
###xml 829 833 <span type="species:ncbi:10090">mice</span>
###xml 937 941 <span type="species:ncbi:10090">mice</span>
###xml 1013 1017 <span type="species:ncbi:10090">mice</span>
After 9 days of training, we moved the hidden platform to a quadrant opposite to that of the previous training session and continued training the mice. As with the initial test (Fig. 1A), GSK+/- mice learned the place of the relocated platform during the first 3 days of training (Fig. 1C), showing comparable spatial memory to that of their WT littermates (Fig. 1F). The swimming speed (motor control ability) and thigmotaxic tendency (emotional control ability) of GSK+/- and WT littermate mice on the first day of training were not significantly different (Supporting information Fig. S4), suggesting that motor and emotional factors could not account for group differences in MWM performance. The relatively wide range of ages of the mice (7-14 months) could not account for differences in cognitive ability of WT and GSK+/- mice (Supporting information Fig. S5). Therefore, these results were due to genetic differences between the mice, and suggest that, although they retained the ability to learn, GSK+/- mice exhibited retrograde amnesia with repeated training. Thus, GSK-3beta reduction does not affect the learning process but does affect the memory maintenance system, such as memory consolidation and/or reconsolidation.
###end p 15
###begin title 16
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
GSK+/- impairs memory reconsolidation
###end title 16
###begin p 17
###xml 334 338 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Nader1">[22]</xref>
###xml 494 498 494 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Dudai1">[24]</xref>
###xml 499 503 499 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Riccio1">[29]</xref>
###xml 574 577 571 574 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 605 608 602 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1091 1098 1088 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g002">Fig. 2A</xref>
###xml 1171 1174 1168 1171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1233 1240 1230 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g002">Fig. 2B</xref>
###xml 1262 1265 1259 1262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1423 1426 1420 1423 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1536 1543 1533 1540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g002">Fig. 2C</xref>
###xml 1620 1627 1617 1624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g002">Fig. 2A</xref>
###xml 1668 1671 1665 1668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1722 1729 1719 1726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g002">Fig. 2E</xref>
###xml 1799 1806 1796 1803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g002">Fig. 2D</xref>
###xml 1840 1843 1837 1840 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1945 1948 1942 1945 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 2055 2058 2052 2055 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 2167 2170 2164 2167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 578 582 <span type="species:ncbi:10090">mice</span>
###xml 627 631 <span type="species:ncbi:10090">mice</span>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
###xml 913 917 <span type="species:ncbi:10090">Mice</span>
###xml 1193 1197 <span type="species:ncbi:10090">mice</span>
###xml 1266 1270 <span type="species:ncbi:10090">mice</span>
###xml 1427 1431 <span type="species:ncbi:10090">mice</span>
###xml 1530 1534 <span type="species:ncbi:10090">mice</span>
###xml 1672 1676 <span type="species:ncbi:10090">mice</span>
###xml 1761 1765 <span type="species:ncbi:10090">mice</span>
###xml 1844 1848 <span type="species:ncbi:10090">mice</span>
###xml 1949 1953 <span type="species:ncbi:10090">mice</span>
###xml 2059 2063 <span type="species:ncbi:10090">mice</span>
###xml 2171 2175 <span type="species:ncbi:10090">mice</span>
A new memory is initially labile and becomes stabilized over time through the process of consolidation. Once stabilized, memory is not permanently fixed and can again become labile if reactivated by recall, which is called reconsolidation. The reconsolidation process is hypothesized to be necessary for updating reactivated memories [22]. Although memory consolidation and reconsolidation are thought to have distinct molecular requirements, both require a protein synthesis-dependent process [24]-[29]. To understand in which process GSK-3beta is involved, we examined GSK+/- mice in a CFC paradigm. GSK+/- and WT littermate mice showed similar freezing times in response to the unconditioning stimulus (US). Twenty-four hours after exposure to the US, mice in the reconsolidation test group were placed in the same context (conditioning stimulus; CS) again without the US to reactivate their memory by recall. Mice in the consolidation group did not receive memory reactivation until the test phase. On day 7, memory performance of both the consolidation and reconsolidation test groups (Fig. 2A) was examined by measuring freezing time. In the consolidation test, GSK+/- and WT littermate mice showed the same level of freezing (Fig. 2B), suggesting that GSK+/- mice are not impaired in the ability to form and consolidate memory. Furthermore, the consolidated memory is maintained for at least 7 days. In contrast, GSK+/- mice showed significantly less freezing in the reconsolidation test on day 7 compared to WT littermate mice (Fig. 2C). Comparison of day 1 and day 7 freezing times in the reconsolidation test (Fig. 2A) revealed that the freezing times of GSK+/- mice decreased significantly from day 1 to day 7 (Fig. 2E), while those of WT littermate mice remained more or less unchanged (Fig. 2D). These results indicate that GSK+/- mice learned and that their memory stabilized over 7 days if memory was not reactivated. However, GSK+/- mice failed to achieve reconsolidation when the memory was reactivated once before testing. Therefore, GSK+/- mice show retrograde amnesia in the CFC reconsolidation test as well as in the MWM test, suggesting that GSK+/- mice may have impaired memory reconsolidation.
###end p 17
###begin title 18
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Memory consolidation and reconsolidation in GSK-3beta heterozygous mice.
###end title 18
###begin p 19
###xml 478 481 478 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 738 741 738 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 971 974 971 974 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1129 1132 1129 1132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1316 1319 1316 1319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1385 1388 1385 1388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 137 141 <span type="species:ncbi:10090">Mice</span>
###xml 445 449 <span type="species:ncbi:10090">mice</span>
###xml 705 709 <span type="species:ncbi:10090">mice</span>
###xml 987 991 <span type="species:ncbi:10090">mice</span>
###xml 1133 1137 <span type="species:ncbi:10090">mice</span>
###xml 1324 1328 <span type="species:ncbi:10090">mice</span>
###xml 1389 1393 <span type="species:ncbi:10090">mice</span>
###xml 1491 1495 <span type="species:ncbi:10090">mice</span>
Memory consolidation and reconsolidation were assessed with a contextual fear-conditioning (CFC) test following the schedule shown in A. Mice were placed in a novel environment (plastic chamber) for 5 min (conditioning stimulus, CS), where they received three electrical foot shocks (unconditioning stimulus, US; shock intensity = 0.5 mV; duration = 2 sec; inter-stimuli interval = 60 sec). In the consolidation test performed 7 days later, the mice (WT littermates, n = 13; GSK+/-, n = 14; 7-14 months old) were placed into the plastic chamber again for 5 min without receiving stimulation, and freezing time was measured (A, B). In the reconsolidation test performed on day 1 and day 7 of training, the mice (WT littermates, n = 17; GSK+/-, n = 11) were placed into the plastic chamber again for 5 min without receiving stimulation, and freezing time was measured (A, C-E). On day 7 of the consolidation test (B), the freezing times of WT littermate (white bar) and GSK+/- (black bar) mice were not significantly different (p = 0.437, Mann-Whitney test). However, on day 7 of the reconsolidation test, the freezing times of GSK+/- mice had decreased significantly compared to that of their WT littermates (c; p = 0.0026, Mann-Whitney test). Comparison of day 1 and day 7 freezing times of WT littermate (D) and GSK+/- (E) mice revealed that, on day 7 of the reconsolidation test, GSK+/- mice showed significantly reduced freezing times (p = 0.0095, Mann-Whitney test), while WT littermate mice did not (p>0.0733, Mann-Whitney test). Results are expressed as means+/-SEM; **, p<0.01.
###end p 19
###begin title 20
Memory reconsolidation requires the activation of GSK-3beta
###end title 20
###begin p 21
###xml 274 278 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Peineau1">[20]</xref>
###xml 418 428 403 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g003">Fig. 3B, C</xref>
###xml 843 853 819 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g003">Fig. 3A, C</xref>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 354 359 <span type="species:ncbi:10090">mouse</span>
To confirm the involvement of GSK-3beta in memory reconsolidation, we first investigated GSK-3beta activity in C57BL/6J mice during consolidation and reconsolidation in a CFC paradigm. Recently, GSK-3beta in synapses have been reported to be involved in synaptic plasticity [20]. This prompted us to examine GSK-3beta activity in synaptic fractions from mouse hippocampus relative to levels of phospho-Ser9 GSK-3beta (Fig. 3B, C). One and twenty-four hours after CS+US presentation, phospho-Ser9 GSK-3beta levels were reduced to about 72% of that of the control group, which did not receive the CS+US presentation, suggesting that GSK-3beta was activated during memory consolidation. One hour after CS presentation during the reconsolidation step, phospho-Ser9 GSK-3beta levels were further and significantly reduced to 50% of control levels (Fig. 3A, C), suggesting that GSK-3beta might be activated during memory consolidation and an additional activation of GSK-3beta might be required during the reconsolidation process.
###end p 21
###begin title 22
Memory reconsolidation requires GSK-3beta activation.
###end title 22
###begin p 23
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 504 508 <span type="species:ncbi:10090">Mice</span>
###xml 1323 1327 <span type="species:ncbi:10090">mice</span>
###xml 1480 1484 <span type="species:ncbi:10090">mice</span>
###xml 2133 2137 <span type="species:ncbi:10090">mice</span>
###xml 2192 2196 <span type="species:ncbi:10090">mice</span>
C57BL/6J mice (7 months old) received contextual fear conditioning according to the test schedule shown in A. Hippocampal GSK-3beta levels were then assessed at different times during the testing. One and twenty-four hours after the presentation of paired conditioned and unconditioned stimuli (CS+US), mice were killed and phospho-Ser9 GSK-3beta and total GSK-3beta levels in hippocampal synaptic fractions were analyzed by Western blotting (B, C). GSK-3beta was found in the synaptic (S) fraction (B). Mice showed reduced phospho-Ser9 GSK-3beta levels after learning and during consolidation and reconsolidation compared to levels measured during "no learning" (C; upper panel). Ratios of phospho-Ser9 GSK-3beta-to-total GSK-3beta levels, which reflect the inhibition of GSK-3beta activity, are shown in the histogram of panel of C. GSK-3beta activity after learning (n = 5) and during consolidation (n = 5) was significantly increased compared to activity measured in the "no learning" group (n = 7). Further significant GSK-3beta activation was seen in the reconsolidation group (n = 4). Statistical analysis was performed using the Tukey's multiple comparison test after one-way ANOVA; *, p<0.05; **, p<0.01; ***, p,0.001. Effects of a GSK-3 inhibitor on memory consolidation and reconsolidation (D-F). Times at which mice received an intraperitoneal injection of GSK-3 inhibitor and the task schedule for contextual fear conditioning are shown in D. Four groups of C57BL/6J mice were intraperitoneally injected with either GSK-3 inhibitor (AR-A014418; 30 mg/kg) or vehicle solution (approximately 100 microl of 10% DMSO/40% PEG solution for each animal) 1 h before consolidation (vehicle, n = 8; inhibitor, n = 8) or reconsolidation (vehicle, n = 8; inhibitor, n = 9). On day 7, memory performance was assessed by measuring freezing times under CS conditions. GSK-3 inhibitor administered before conditioning did not significantly affect memory performance on day 7 (E; p = 0.798, Mann-Whitney test). In contrast, when GSK-3 inhibitor was administered before reconsolidation, on day 7 freezing times of GSK-3 inhibitor-treated mice were significantly less than those of vehicle-treated mice (F; p = 0.036, Mann-Whitney test). Results are expressed as means+/-SEM; *, p<0.05.
###end p 23
###begin p 24
###xml 179 182 176 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 670 677 664 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g003">Fig. 3D</xref>
###xml 851 858 845 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003540.s006">Fig. S6</xref>
###xml 945 952 939 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g003">Fig. 3E</xref>
###xml 1063 1070 1057 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g003">Fig. 3F</xref>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 431 435 <span type="species:ncbi:10090">mice</span>
If this additional GSK-3beta activation is involved in memory reconsolidation, inhibition of GSK-3 might produce the same effects on memory reconsolidation as that observed in GSK+/- mice. Thus, we next investigated the effect of GSK-3beta inhibition on memory maintenance by intraperitoneal injection of the GSK-3 inhibitor AR-A014418 (30 mg/kg), followed by training on the CFC paradigm. To confirm inhibition of GSK-3, C57BL/6J mice were treated with the GSK-3 inhibitor before the consolidation step or before the reconsolidation step (1 h before CS+US presentation in the consolidation test, or 1 h before CS presentation in the reconsolidation test, respectively; Fig. 3D). The GSK-3 inhibitor reduced tau phosphorylation by 70% compared to the vehicle control, suggesting that the treatment inhibited GSK-3 activity (see Supporting information Fig. S6). Inhibiting GSK-3 before the consolidation step did not impair memory consolidation (Fig. 3E), but GSK-3 inhibition applied before the reconsolidation step significantly impaired memory reconsolidation (Fig. 3F). Thus, the memory reconsolidation step is more sensitive to GSK-3beta activity than the memory consolidation step, and these results indicate that activation of GSK-3beta might be required for memory reconsolidation.
###end p 24
###begin title 25
Discussion
###end title 25
###begin p 26
The genetic reduction of GSK-3beta and the pharmacological inhibition of GSK-3 impaired reconsolidation of hippocampus-dependent place memory, as demonstrated in the CFC test, a test that assesses hippocampus-mediated memory consolidation and reconsolidation. Hence, GSK-3beta may be involved in memory reconsolidation in the hippocampus. The mechanism of memory formation and maintenance in the hippocampus, however, may also involve coordinated activity in other brain regions. Clearly, more work is needed to clarify the role of GSK-3beta in cortex and other brain regions.
###end p 26
###begin p 27
###xml 146 150 146 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-GmezSintes1">[30]</xref>
###xml 155 158 155 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 258 261 254 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 159 163 <span type="species:ncbi:10090">mice</span>
Although mice expressing the dominant negative form of GSK-3 display neuronal damage in striatum and cortex accompanied by impaired limb mobility [30], GSK+/- mice did not display these phenomena. This discrepancy may due to GSK-3alpha activity. Although GSK+/- reduces GSK-3beta activity without affecting GSK-3alpha, dominant negative GSK-3 reduces both GSK-3alpha and GSK-3beta activity in striatum and cortex. This reduction may cause neuronal vulnerability.
###end p 27
###begin p 28
###xml 133 136 133 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 246 249 246 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 377 380 377 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 677 681 674 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Artinian1">[31]</xref>
###xml 682 686 679 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Rossato1">[33]</xref>
###xml 912 915 903 906 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
###xml 435 439 <span type="species:ncbi:10090">mice</span>
###xml 895 899 <span type="species:ncbi:10090">mice</span>
###xml 916 920 <span type="species:ncbi:10090">mice</span>
Both place learning in the MWM and context learning in the CFC paradigm reflect mainly hippocampal-dependent learning and memory. GSK+/- mice showed retrograde amnesia in the MWM and CFC paradigms. Using the CFC paradigm, we demonstrated that GSK+/-, or pharmacological inhibition of GSK-3, impaired memory reconsolidation without affecting memory consolidation. Therefore, GSK+/- mice-in which GSK-3beta is genetically reduced-and WT mice treated with a GSK-3 inhibitor lose their ability to reconsolidate memory. Injecting a protein synthesis inhibitor (anisomycin) into dorsal hippocampus inhibits memory consolidation and reconsolidation in both place and context learning [31]-[33]. Thus, if GSK-3beta is involved in a common mechanism of memory reconsolidation shared by both tasks, we would expect that the genetic reduction of GSK-3beta to also impair memory reconsolidation of affected mice. Indeed, GSK+/- mice did display impaired memory reconsolidation in both MWM and CFC tests.
###end p 28
###begin p 29
###xml 40 43 40 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 84 91 84 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g001">Fig. 1D</xref>
###xml 143 146 143 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 182 189 182 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g001">Fig. 1E</xref>
###xml 216 220 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Artinian1">[31]</xref>
###xml 803 807 803 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Suzuki1">[34]</xref>
###xml 956 959 953 956 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
During the first 3 days of training, GSK+/- mice did not exhibit memory impairment (Fig. 1D). However, after 9 days of repetitive training, GSK+/- mice exhibited retrograde amnesia (Fig. 1E). Artinian and colleagues [31] found that injecting anisomycin into CA3 after a single reactivation, inhibited memory reconsolidation following 4 sessions of three trials in one day in a place-learning version of the MWM paradigm. In our MWM training protocol, mice were repeatedly trained three trials everyday. The strength of memory in each day in our MWM protocol seems to be weaker than that in Artinians' protocol. The temporal dynamics of memory reconsolidation depend on the strength and age of the memory, such that younger and weaker memories are more easily reconsolidated than older and stronger ones [34]. Therefore, more than three days of repetitive training may be required for inhibiting memory reconsolidation by genetic reduction of GSK-3beta (GSK+/-) under our MWM protocol.
###end p 29
###begin p 30
###xml 494 497 491 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 666 670 663 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Morris1">[27]</xref>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
One caveat in interpreting a retrograde amnesia effect in the CFC paradigm is the possibility of extinction of the conditioned response, because retrograde amnesia in repeated exposure to the same context without reinforcement can produce extinction. Therefore, it is possible that GSK-3beta inhibition-induced retrograde amnesia may be due to facilitation of extinction or impairment of reconsolidation. However, the facilitation-of-extinction notion cannot explain the result showing that GSK+/- mice displayed retrograde amnesia upon repetitive training in the MWM. Since maintenance of spatial memory in the MWM requires memory consolidation and reconsolidation [27] and since MWM training is performed under the existence of a reinforcer, spatial memory may not be affected by memory extinction. Therefore, retrograde amnesia related to GSK-3beta inhibition could be due to an impairment of memory reconsolidation, not to facilitation of extinction.
###end p 30
###begin p 31
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Morris2">[35]</xref>
###xml 270 274 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Frey1">[36]</xref>
###xml 373 377 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Peineau1">[20]</xref>
###xml 443 447 437 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Hooper1">[37]</xref>
###xml 650 654 638 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Engel3">[38]</xref>
NMDA-induced bidirectional synaptic plasticity (long term potentiation, LTP; long term depression, LTD) is believed to underlie memory formation [35]. During LTP, neurons store relevant information by synaptic tagging, which is thought to underlie a stable memory trace [36]. Recently, GSK-3beta activation has been reported to be required for NMDA-dependent LTD induction [20]. Furthermore, overexpression of GSK-3beta inhibits LTP induction [37]. Therefore, GSK-3beta could modulate the balancing of LTP and LTD in an activity-dependent manner. Overexpression of GSK-3beta impairs acquisition of reference memory in a novel object recognition task [38]. As we have shown in this report, the inhibition of GSK-3beta blocks memory reconsolidation but not memory acquisition or consolidation. These observations suggest that activated GSK-3beta may contribute to memory reconsolidation by controlling LTP/LTD balance.
###end p 31
###begin p 32
###xml 303 307 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Diamond1">[39]</xref>
If LTP and LTD contribute to the formation and maintenance of memory traces, memory acquisition and consolidation processes may preferentially depend on LTP. In the case of memory reconsolidation, LTD may be more important for maintaining a prior potentiated circuit by competitive synaptic maintenance [39]. GSK-3beta activation may help protect a stable memory trace from corruption through additional synaptic connections or changes during recall and reconsolidation. Although this idea may be supported by the observation that greater activation of GSK-3beta is required in the reconsolidation process rather than in the consolidation process, more precise mechanisms need to be clarified.
###end p 32
###begin p 33
###xml 424 428 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Kimura1">[40]</xref>
GSK-3beta is involved in NFT formation in AD. During normal aging, NFTs are observed in the entorhinal cortex. This may represent a very early pathological change of sporadic AD. Because memory reconsolidation is required for GSK-3beta activation, tau might be hyperphosphorylated when memory is reconsolidated. As we recently reported, the accumulation of hyperphosphorylated tau impairs learning and memory during old age [40]. Therefore, frequent activation of memory reconsolidation in older brains may damage learning and memory through the hyperphosphorylation of tau. Thus, GSK-3beta does have an important role in memory maintenance in the adult brain, but it may also cause NFT formation in the aged brain.
###end p 33
###begin title 34
Materials and Methods
###end title 34
###begin title 35
Animals
###end title 35
###begin p 36
###xml 85 88 73 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 438 445 423 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g003">Fig. 3a</xref>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
###xml 160 164 <span type="species:ncbi:10090">Mice</span>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
###xml 376 380 <span type="species:ncbi:10090">mice</span>
###xml 447 451 <span type="species:ncbi:10090">mice</span>
Male C57/BL6J mice aged approximately7 months were used for all experiments. Male GSK+/- mice (7-14 months) were maintained by backcrossing with C57/BL6J mice. Mice were individually housed and kept on a 12-h light/dark schedule. All mice had free access to food and water. To assess GSK-3beta activation during memory consolidation and reconsolidation, we subjected C57BL/6J mice to a CFC paradigm. At the indicated time points shown in Fig. 3a, mice were killed by cervical dislocation and their hippocampi were removed and prepared for biochemical analysis of GSK-3beta. All experiments were performed according to procedures approved by the Animal Experiments Committee of the Institute of Physical and Chemical Research (RIKEN).
###end p 36
###begin title 37
Antibodies
###end title 37
###begin p 38
###xml 34 40 <span type="species:ncbi:9986">rabbit</span>
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
###xml 122 128 <span type="species:ncbi:9986">rabbit</span>
We used the following antibodies: rabbit polyclonal anti-GSK-3, mouse monoclonal anti-GSK-3beta (Transduction Lab, Inc.); rabbit polyclonal anti-phospho-Ser9 GSK-3beta (Cell Signaling Technology, Inc.).
###end p 38
###begin title 39
Western blotting
###end title 39
###begin p 40
###xml 339 340 319 320 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 342 343 322 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 402 403 382 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 790 791 770 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 846 847 826 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 994 995 974 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1075 1076 1055 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 609 614 <span type="species:ncbi:10090">mouse</span>
Mouse hippocampi were homogenized in Tris-buffered saline (TBS; 10 mM Tris, 150 mM NaCl [pH 7.4]) containing protease inhibitors (1 microg/ml antipine, 5 microg/ml pepstatin, 5 microg/ml leupeptin, 2 microg/ml aprotinin, and 0.5 microM 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride) and phosphatase inhibitors (1 mM NaF, 0.4 mM Na3VO4, and 0.5 mM okadaic acid). After centrifugation at 27,000 g for 20 min, the supernatant was collected. TBS-soluble materials were solubilized in Laemmli sample buffer and subjected to SDS-PAGE. Next, we purified synaptic fractions from hippocampus. Hippocampi from mouse brains were homogenized in 8 volumes of 10 mM HEPES buffer containing protease inhibitors and phosphatase inhibitors, 5 mM EDTA, and 300 mM sucrose, and centrifuged at 12,000 g for 10 min. The supernatant was centrifuged at 39,800 g for 40 min, and the nuclear fraction was completely removed. The synaptic fraction was purified from the supernatant by centrifugation at 120,000 g for 40 min. The cytoplasmic fraction was obtained by centrifugation at 260,000 g for 2 h. Synaptic and cytoplasmic fractions were subjected to SDS-PAGE, and separated proteins were blotted onto nitrocellulose membranes (Schleicher & Schuell Bioscience). The membranes were then incubated with primary antibody, followed by the species-appropriate HRP-conjugated secondary antibody. Chemiluminescent detection (ECL; GE Healthcare Bio Science) was used for visualization. Quantitation and visual analysis of immunoreactivity were performed with a computer-linked LAS-3000 Bio-Imaging Analyzer System (Fujifilm).
###end p 40
###begin title 41
Morris water maze test
###end title 41
###begin p 42
###xml 200 204 200 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Morris2">[35]</xref>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 235 240 <span type="species:ncbi:10090">mouse</span>
###xml 280 285 <span type="species:ncbi:10090">mouse</span>
###xml 327 332 <span type="species:ncbi:10090">mouse</span>
###xml 410 415 <span type="species:ncbi:10090">mouse</span>
###xml 569 574 <span type="species:ncbi:10090">mouse</span>
###xml 751 756 <span type="species:ncbi:10090">mouse</span>
###xml 772 777 <span type="species:ncbi:10090">mouse</span>
###xml 903 908 <span type="species:ncbi:10090">mouse</span>
To assess place learning and memory performance of mice, we used a cylindrical test apparatus (1 m in diameter) and task closely fashioned after the Morris water maze according to our previous report [35]. To assess learning, for each mouse we calculated the distance between the mouse and the platform every 0.5 sec until the mouse reached the platform. Next, we calculated the total distance traveled by the mouse as it searched for the platform. This error score was used as a measure of learning performance. Lower scores indicated better learning and memory. Each mouse was subjected to three learning trials per day for nine successive days. A single probe test was given on the tenth day, in which the platform was removed from the maze in the mouse's absence. The mouse was introduced into the maze as before and allowed to search for the missing platform for 60 sec. The percentage of time the mouse spent searching in each quadrant was used as an index of memory performance. Statistical analyses were conducted using PRISM4 (GraphPad Software Inc.). Data were analyzed using the Friedman test or two-way ANOVA, unless noted otherwise.
###end p 42
###begin title 43
Contextual fear-conditioning (CFC) test for memory consolidation and reconsolidation
###end title 43
###begin p 44
###xml 90 93 87 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 952 956 <span type="species:ncbi:10090">mice</span>
###xml 1202 1206 <span type="species:ncbi:10090">mice</span>
###xml 1415 1419 <span type="species:ncbi:10090">mice</span>
To test the effect of GSK-3beta reduction on memory consolidation and reconsolidation, GSK+/- mice and GSK-3 inhibitor-treated C57BL/6J mice were randomly selected and assessed on a CFC test. The test apparatus consisted of a 60 cmx40 cmx40 cm sound-proof box containing a 10 cmx10 cmx10 cm transparent plastic chamber with a steel grid floor (for delivering electrical foot shocks) and a CCD camera. To examine memory consolidation, we exposed individual to the novel environment (plastic chamber) for 5 min (conditioning stimulus, CS), and then delivered three sequential foot shocks (unconditioning stimulus, US; shock intensity = 0.5 mV; duration = 2 sec; inter-stimuli interval = 60 sec). Seven days after CS presentation, conditioned animals were re-exposed to the same plastic chamber for 4 min, and freezing time was measured with custom software based on Matlab (version 7.2, Mathworks Co. Ltd.). To examine memory reconsolidation, we exposed mice to the environmental CS for 5 min. One day after CS presentation, conditioned animals were exposed to the same plastic chamber for 4 min, and freezing time was monitored as before. Six days after first being exposed to the same plastic chamber, mice were re-exposed to the chamber, and memory reconsolidation was assessed by measuring freezing time. The same behavioral analyses were applied in experiments testing the affect of GSK-3 inhibition on C57BL/6J mice and biochemical analysis of GSK-3beta activity during contextual fear conditioning.
###end p 44
###begin title 45
Supporting Information
###end title 45
###begin p 46
###xml 1667 1671 1620 1624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0003540-Peineau1">[20]</xref>
###xml 1852 1859 1805 1812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0003540.s002">Fig. S2</xref>
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 312 316 <span type="species:ncbi:10090">mice</span>
###xml 426 430 <span type="species:ncbi:10090">mice</span>
###xml 579 583 <span type="species:ncbi:10090">mice</span>
###xml 928 932 <span type="species:ncbi:10090">mice</span>
###xml 1015 1019 <span type="species:ncbi:10090">mice</span>
###xml 1142 1146 <span type="species:ncbi:10090">mice</span>
###xml 1416 1420 <span type="species:ncbi:10090">mice</span>
###xml 1585 1589 <span type="species:ncbi:10090">mice</span>
###xml 1618 1622 <span type="species:ncbi:10090">mice</span>
###xml 1684 1688 <span type="species:ncbi:10090">mice</span>
###xml 1819 1823 <span type="species:ncbi:10090">mice</span>
###xml 1869 1873 <span type="species:ncbi:10090">mice</span>
Generation of GSK-3beta heterozygote mouse. Using homologous recombination, we flanked the exon-encoding catalytic domain of GSK-3beta with loxP elements. Floxed GSK-3beta mice were crossed with mice expressing Cre recombinase under the control of the EIIa promoter, and their progeny were crossed with C57/BL6J mice (A). The offspring of this latter cross underwent PCR tail DNA analysis using the primer sets indicated, and mice harboring the delta allele were selected (B). The brains of six wild-type (GSK-3beta+/+; WT littermate) and six heterozygous (GSK-3beta+/-; GSK+/-) mice were homogenized and GSK-3alpha and GSK-3beta expression levels were examined by Western blotting (C). GSK-3beta (D) and GSK-3{lwoer case alpha} (F) expression levels were quantified with a computer-linked LAS-3000 Bio-Imaging Analyzer System. Although there were no significant differences in the GSK-3alpha expression levels of WT and GSK+/- mice (n = 6, p = 0.1797, Mann-Whitney test), the GSK-3beta expression levels of GSK+/- mice were about 50% of that of the WT littermates (n = 6, p = 0.0022, Mann-Whitney test). Reduced GSK-3beta activity in GSK+/- mice was confirmed by incorporating radiolabeled 32P into GSK-3 substrate peptide (E) (n = 6, p = 0.0022, Mann-Whitney test). Results are expressed as means+/-SEM; *, p<0.05; **, p<0.01; ***, p<0.001. The total amount (C, E) and relative activity (F) of GSK-3beta in GSK+/- mice were approximately 50% and 70%, respectively, of those in WT littermates. The total amount and relative activity of GSK-3alpha, a homologue of GSK-3beta, in GSK+/- mice were similar to those in WT mice (C, D). Consistent with a previously report [20], our GSK+/- mice were healthy, fertile, and showed no changes in circadian rhythm, life span, motor control, and locomotor activity compared to WT mice (see Supporting information Fig. S2). GSK+/- mice, however, displayed reduced GSK-3beta activity, without showing GSK-3alpha compensation.
###end p 46
###begin p 47
(0.13 MB PDF)
###end p 47
###begin p 48
Click here for additional data file.
###end p 48
###begin p 49
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 123 127 <span type="species:ncbi:10090">mice</span>
###xml 180 184 <span type="species:ncbi:10090">mice</span>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 444 448 <span type="species:ncbi:10090">mice</span>
###xml 533 537 <span type="species:ncbi:10090">mice</span>
###xml 660 664 <span type="species:ncbi:10090">mice</span>
###xml 773 777 <span type="species:ncbi:10090">mice</span>
Basic characteristics (circadian rhythm, locomotor activity, motor control activity, and life span) of GSK+/- mice. GSK+/- mice showed similar awake/rest patterns as WT littermate mice when housed under 12-h light/dark conditions (A). After measuring the locomotor activity of three GSK+/- and three WT mice for 3 successive days under home-cage conditions, we found that the total daily locomotor activity (number of beam crossings) of GSK+/- mice during circadian monitoring did not significantly differ from that of WT littermate mice (B). Motor control activity (C) was tested using an accelerated rotarod test (1.5-15 rpm/3 min). GSK+/- and WT littermate mice did not show significant motor-skill differences (Mann-Whitney test). Furthermore, GSK+/- and WT littermate mice showed comparable survival times (D) (Log-rank test, p>0.05).
###end p 49
###begin p 50
(0.11 MB PDF)
###end p 50
###begin p 51
Click here for additional data file.
###end p 51
###begin p 52
###xml 455 462 455 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g001">Fig. 1B</xref>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 289 293 <span type="species:ncbi:10090">mice</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 538 543 <span type="species:ncbi:10090">mouse</span>
###xml 628 633 <span type="species:ncbi:10090">mouse</span>
###xml 704 709 <span type="species:ncbi:10090">mouse</span>
Path length (A) and latency (B) of WT and GSK+/- mice in the MWM during 9 days of training. During the first 3 days of training, both WT and GSK+/- mice showed reduced latency to platform and shorter path-length to platform after repetitive training. After longer, subsequent training, WT mice showed reduced latency to platform and shorter path-length to platform, but GSK+/- mice did not. This tendency is similarly reflected in the error score plot of Fig. 1B. Because the error score is a value representing the cumulative distance a mouse travels to find the platform during each trial, the error score not only reflects a mouse's path-length information during training but also it also reflects a mouse's trace information until it reaches the platform.
###end p 52
###begin p 53
(0.08 MB PDF)
###end p 53
###begin p 54
Click here for additional data file.
###end p 54
###begin p 55
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
The emotional responses of GSK+/- mice to the Morris water maze were determined by assessing swim speed (A) and thigmotaxis tendency (B). In this analysis, we used only data obtained from the first training day to omit the influence of learning. Both emotional parameters indicated that no significant differences exist between GSK+/- (n = 19) and WT littermate (n = 20) mice (p>0.05, Mann-Whitney test).
###end p 55
###begin p 56
(0.05 MB PDF)
###end p 56
###begin p 57
Click here for additional data file.
###end p 57
###begin p 58
###xml 169 176 169 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0003540-g001">Fig. 1E</xref>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
The effect of aging on place memory formation was investigated by comparing probe test scores (percentage of stay time in the target quadrant) after 9 days of training (Fig. 1E). Three age groups (7-9 months, 10-11 months, 12-14 months) of WT and GSK+/- mice were assessed. Although the relatively wide range of ages, 7-14 months, did not affect place memory formation (two-way ANOVA analysis; aging factor, F = 0.4772,p = 14.86), genotype, WT vs. GSK+/-, did formation (two-way ANOVA analysis; genotype factor, F = 6.020,p = 0.0196).
###end p 58
###begin p 59
(0.08 MB PDF)
###end p 59
###begin p 60
Click here for additional data file.
###end p 60
###begin p 61
AR-A014418 inhibited tau phosphorylation, as shown in the Western blots probed with TauC, a phosphorylation independent anti-tau antibody; PHF1 (generously provided by Dr. Peter Davies, Albert Einstein College of Medicine, NY), a phosphorylation-dependent anti-tau antibody; and Tau1 (CHEMICON, Temecula, CA), a non-phosphorylation-dependent anti-tau antibody, which recognizes non-phosphorylated Ser199 and Ser202. AR-A014418 reduced tau phosphorylation (PHF1 immunoreactivity was reduced, Tau1 immunoreactivity was increased, TauC immunoreactivity was unchanged) to 70% of that produced by vehicle injection alone, suggesting that peripheral treatment with a GSK-3 inhibitor inhibited GSK-3 activity by 30%.
###end p 61
###begin p 62
(0.08 MB PDF)
###end p 62
###begin p 63
Click here for additional data file.
###end p 63
###begin title 64
References
###end title 64
###begin article-title 65
Molecular cloning and expression of glycogen synthase kinase-3/factor A.
###end article-title 65
###begin article-title 66
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling.
###end article-title 66
###begin article-title 67
The glamour and gloom of glycogen synthase kinase-3.
###end article-title 67
###begin article-title 68
GSK-3 is essential in the pathogenesis of Alzheimer's disease.
###end article-title 68
###begin article-title 69
Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions.
###end article-title 69
###begin article-title 70
Schizophrenia as a GSK-3 dysregulation disorder.
###end article-title 70
###begin article-title 71
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Regulation of glycogen synthase kinase-3 in patients with affective disorders.
###end article-title 71
###begin article-title 72
Tau proteins and neurofibrillary degeneration.
###end article-title 72
###begin article-title 73
Molecular mechanism of Alzheimer's neurofibrillary degeneration and therapeutic intervention.
###end article-title 73
###begin article-title 74
The disordered neuronal cytoskeleton in Alzheimer's disease.
###end article-title 74
###begin article-title 75
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.
###end article-title 75
###begin article-title 76
Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase.
###end article-title 76
###begin article-title 77
Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.
###end article-title 77
###begin article-title 78
Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons.
###end article-title 78
###begin article-title 79
Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo.
###end article-title 79
###begin article-title 80
###xml 12 15 <span type="species:ncbi:10116">rat</span>
Exposure of rat hippocampal neurons to amyloid beta peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3 beta.
###end article-title 80
###begin article-title 81
Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity.
###end article-title 81
###begin article-title 82
###xml 46 61 <span type="species:ncbi:10090">transgenic mice</span>
Cooexpression of FTDP-17 tau and GSK-3beta in transgenic mice induce tau polymerization and neurodegeneration.
###end article-title 82
###begin article-title 83
###xml 28 43 <span type="species:ncbi:10090">transgenic mice</span>
Spatial learning deficit in transgenic mice that conditionally over-express GSK-3beta in the brain but do not form tau filaments.
###end article-title 83
###begin article-title 84
LTP Inhibits LTD in the Hippocampus via Regulation of GSK3[beta].
###end article-title 84
###begin article-title 85
Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.
###end article-title 85
###begin article-title 86
Memory traces unbound.
###end article-title 86
###begin article-title 87
Context memories and reactivation: constraints on the reconsolidation hypothesis.
###end article-title 87
###begin article-title 88
Rites of Passage of the Engram: Reconsolidation and the Lingering Consolidation Hypothesis.
###end article-title 88
###begin article-title 89
Stability of Retrieved Memory: Inverse Correlation with Trace Dominance.
###end article-title 89
###begin article-title 90
Reconsolidation and Extinction of Conditioned Fear: Inhibition and Potentiation.
###end article-title 90
###begin article-title 91
Memory Reconsolidation: Sensitivity of Spatial Memory to Inhibition of Protein Synthesis in Dorsal Hippocampus during Encoding and Retrieval.
###end article-title 91
###begin article-title 92
The labile nature of consolidation theory.
###end article-title 92
###begin article-title 93
Reconsolidation reconsidered.
###end article-title 93
###begin article-title 94
###xml 87 102 <span type="species:ncbi:10090">transgenic mice</span>
Neuronal apoptosis and reversible motor deficit in dominant-negative GSK-3 conditional transgenic mice.
###end article-title 94
###begin article-title 95
###xml 169 173 <span type="species:ncbi:10090">mice</span>
Reactivation with a simple exposure to the experimental environment is sufficient to induce reconsolidation requiring protein synthesis in the hippocampal CA3 region in mice.
###end article-title 95
###begin article-title 96
Cellular and systems reconsolidation in the hippocampus.
###end article-title 96
###begin article-title 97
Retrieval induces hippocampal-dependent reconsolidation of spatial memory.
###end article-title 97
###begin article-title 98
Memory reconsolidation and extinction have distinct temporal and biochemical signatures.
###end article-title 98
###begin article-title 99
Elements of a neurobiological theory of the hippocampus: the role of activity-dependent synaptic plasticity in memory.
###end article-title 99
###begin article-title 100
Synaptic tagging: implications for late maintenance of hippocampal long-term potentiation.
###end article-title 100
###begin article-title 101
Glycogen synthase kinase-3 inhibition is integral to long-term potentiation.
###end article-title 101
###begin article-title 102
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
Full reversal of Alzheimer's disease-like phenotype in a mouse model with conditional overexpression of glycogen synthase kinase-3.
###end article-title 102
###begin article-title 103
Competitive interactions between endogenous LTD and LTP in the hippocampus underlie the storage of emotional memories and stress-induced amnesia.
###end article-title 103
###begin article-title 104
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 107 112 <span type="species:ncbi:9606">human</span>
Hyperphosphorylated tau in parahippocampal cortex impairs place learning in aged mice expressing wild-type human tau.
###end article-title 104
###begin p 105
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 105
###begin p 106
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Grant-in-Aid for Scientific Research on Priority Areas (Research on Pathomechanisms on Brain Disorders) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.
###end p 106

